Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Anti-H. pylori compound from Toyama

July 26, 1996

Thiophene and thiophene derivatives described by Sankyo as ulcer treatment

July 26, 1996

Anti-H. pylori cephem compounds described by Fujisawa

July 26, 1996

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Lamivudine for treatment of hepatitis B covered under U.S. patent

July 12, 1996

Otsuka peptide IL-1 production inhibitors in pipeline

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...